The Role of Small Intestinal Bacterial Overgrowth in Obesity and Its Related Diseases.

[1]  F. Retornaz,et al.  Small Intestinal Bacterial Overgrowths and Intestinal Methanogen Overgrowths Breath Testing in a Real-Life French Cohort , 2022, Clinical and translational gastroenterology.

[2]  T. Pintar,et al.  Small Intestinal Bacterial Overgrowth in Patients with Roux-en-Y Gastric Bypass and One-Anastomosis Gastric Bypass , 2022, Obesity Surgery.

[3]  Mohammad Shafi Kuchay,et al.  Toll-like receptors and metabolic (dysfunction)-associated fatty liver disease. , 2022, Pharmacological research.

[4]  Qi Zhang,et al.  Gut microbiota–mitochondrial inter-talk in non-alcoholic fatty liver disease , 2022, Frontiers in Nutrition.

[5]  W. Pories,et al.  Bacteria with potential: Improving outcomes through probiotic use following Roux‐en‐Y gastric bypass , 2022, Clinical obesity.

[6]  A. H. D. A. Morais,et al.  Intestinal Barrier Permeability in Obese Individuals with or without Metabolic Syndrome: A Systematic Review , 2022, Nutrients.

[7]  Jingjing Cai,et al.  The contribution of the gut-liver axis to the immune signaling pathway of NAFLD , 2022, Frontiers in Immunology.

[8]  C. Labenz,et al.  Diabetes mellitus – risk factor and potential future target for hepatic encephalopathy in patients with liver cirrhosis? , 2022, Metabolic Brain Disease.

[9]  S. Man,et al.  Oligosaccharide and short-chain fatty acid: A double-edged sword in obese mice by regulating food intake and fat synthesis. , 2022, Food research international.

[10]  D. Sanders,et al.  Links between celiac disease and small intestinal bacterial overgrowth: A systematic review and meta‐analysis , 2022, Journal of gastroenterology and hepatology.

[11]  M. Pimentel,et al.  Small Intestine Bacterial Overgrowth Can Form an Indigenous Proinflammatory Environment in the Duodenum: A Prospective Study , 2022, Microorganisms.

[12]  E. Quigley,et al.  Small Intestinal Bacterial Overgrowth, Pathophysiology and its implications for Definition and Management. , 2022, Gastroenterology.

[13]  T. Pischon,et al.  Gut Microbiome Composition in Obese and Non-Obese Persons: A Systematic Review and Meta-Analysis , 2021, Nutrients.

[14]  James B. Mitchell,et al.  The antioxidant tempol transforms gut microbiome to resist obesity in female C3H mice fed a high fat diet , 2021, Free radical biology & medicine.

[15]  X. Hou,et al.  Efficacy of rifaximin in treating with small intestine bacterial overgrowth: a systematic review and meta-analysis , 2021, Expert review of gastroenterology & hepatology.

[16]  Fengqin Wang,et al.  Faecal microbiota transplantation‐mediated jejunal microbiota changes halt high‐fat diet‐induced obesity in mice via retarding intestinal fat absorption , 2021, Microbial biotechnology.

[17]  Brian J. Bennett,et al.  High-fat diet–induced colonocyte dysfunction escalates microbiota-derived trimethylamine N-oxide , 2021, Science.

[18]  Zheng Jiang,et al.  The prevalence of small intestinal bacterial overgrowth in diabetes mellitus: a systematic review and meta-analysis , 2021, Aging.

[19]  J. Walter,et al.  Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial , 2021, Nature Medicine.

[20]  E. Núñez,et al.  Bacterial metabolites trimethylamine N-oxide and butyrate as surrogates of small intestinal bacterial overgrowth in patients with a recent decompensated heart failure , 2021, Scientific Reports.

[21]  T. Kanneganti,et al.  NLRP3 inflammasome in cancer and metabolic diseases , 2021, Nature Immunology.

[22]  R. Playford,et al.  Effects of Bovine Colostrum with or without Egg on In Vitro Bacterial-Induced Intestinal Damage with Relevance for SIBO and Infectious Diarrhea , 2021, Nutrients.

[23]  Xusheng Guo,et al.  Understanding the Effects of Gut Microbiota Dysbiosis on Nonalcoholic Fatty Liver Disease and the Possible Probiotics Role: Recent Updates , 2021, International journal of biological sciences.

[24]  Dongfeng Chen,et al.  Clinical efficacy of fecal microbiota transplantation for patients with small intestinal bacterial overgrowth: a randomized, placebo-controlled clinic study , 2021, BMC Gastroenterology.

[25]  C. Glass,et al.  Epigenetic Regulation of Kupffer Cell Function in Health and Disease , 2021, Frontiers in Immunology.

[26]  M. Fisberg,et al.  Intestinal permeability and small intestine bacterial overgrowth in excess weight adolescents , 2020, Pediatric obesity.

[27]  H. Fukui.  Leaky Gut and Gut-Liver Axis in Liver Cirrhosis: Clinical Studies Update , 2020, Gut and liver.

[28]  Allison R. Schulman,et al.  Small Intestinal Bacterial Overgrowth: Clinical Presentation in Patients with Roux-en-Y Gastric Bypass , 2020, Obesity Surgery.

[29]  B. Massey,et al.  Small Intestinal Bacterial Overgrowth Syndrome: A Guide for the Appropriate Use of Breath Testing , 2020, Digestive Diseases and Sciences.

[30]  R. Schmitz,et al.  The host-associated archaeome , 2020, Nature Reviews Microbiology.

[31]  A. Argentiero,et al.  Role of Small Intestinal Bacterial Overgrowth (SIBO) and Inflammation in Obese Children , 2020, Frontiers in Pediatrics.

[32]  Xiao-yi Zhu,et al.  Association between small intestinal bacterial overgrowth and beta-cell function of type 2 diabetes , 2020, The Journal of international medical research.

[33]  A. Sharma,et al.  Small Intestinal Bacterial Overgrowth: Comprehensive Review of Diagnosis, Prevention, and Treatment Methods , 2020, Cureus.

[34]  A. Di Leo,et al.  The Influence of Small Intestinal Bacterial Overgrowth in Digestive and Extra-Intestinal Disorders , 2020, International journal of molecular sciences.

[35]  S. Pungpapong,et al.  Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease: a systematic review and meta-analysis , 2020, European journal of gastroenterology & hepatology.

[36]  S. Rana,et al.  Oxidative stress and inflammatory markers in type 2 diabetic patients , 2020, European journal of clinical investigation.

[37]  S. Ikramuddin,et al.  Nonalcoholic Steatohepatitis: A Review. , 2020, JAMA.

[38]  J. Rabinowitz,et al.  Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate , 2020, Nature.

[39]  A. de Gottardi,et al.  The gut-liver axis in liver disease: pathophysiological basis for therapy. , 2020, Journal of hepatology.

[40]  C. Lepage,et al.  Study of Small Intestinal Bacterial Overgrowth in a Cohort of Patients with Abdominal Symptoms Who Underwent Bariatric Surgery , 2020, Obesity Surgery.

[41]  K. Clément,et al.  Nonalcoholic fatty liver disease: modulating gut microbiota to improve severity? , 2020, Gastroenterology.

[42]  M. Farhangi,et al.  Gut microbiota‐derived metabolite trimethylamine N‐oxide (TMAO) potentially increases the risk of obesity in adults: An exploratory systematic review and dose‐response meta‐ analysis , 2020, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[43]  U. Ghoshal,et al.  Gut microbiota abnormalities, small intestinal bacterial overgrowth, and non-alcoholic fatty liver disease: An emerging paradigm , 2020, Indian Journal of Gastroenterology.

[44]  M. Pimentel,et al.  ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth. , 2020, The American journal of gastroenterology.

[45]  A. Shin,et al.  Risk Factors Associated With Upper Aerodigestive Tract or Coliform Bacterial Overgrowth of the Small Intestine in Symptomatic Patients , 2020, Journal of clinical gastroenterology.

[46]  Ji Miao,et al.  Trimethylamine N-Oxide Binds and Activates PERK to Promote Metabolic Dysfunction. , 2019, Cell metabolism.

[47]  M. Pimentel,et al.  Breath Test Gas Patterns in Inflammatory Bowel Disease with Concomitant Irritable Bowel Syndrome-Like Symptoms: A Controlled Large-Scale Database Linkage Analysis , 2019, Digestive Diseases and Sciences.

[48]  F. Perri,et al.  Breath Tests for the Non-invasive Diagnosis of Small Intestinal Bacterial Overgrowth: A Systematic Review With Meta-analysis , 2019, Journal of neurogastroenterology and motility.

[49]  L. Lipscombe,et al.  Review: Diabetes, Obesity and Cancer - Pathophysiology and Clinical Implications. , 2019, Endocrine reviews.

[50]  F. Lukens,et al.  Obesity and Risk of Small Intestine Bacterial Overgrowth: A Systematic Review and Meta-Analysis , 2019, Digestive Diseases and Sciences.

[51]  D. Dumitrascu,et al.  GASTROINTESTINAL MOTILITY DISORDERS IN OBESITY. , 2019, Acta endocrinologica.

[52]  K. Clément,et al.  Acyl-CoA-Binding Protein Is a Lipogenic Factor that Triggers Food Intake and Obesity. , 2019, Cell metabolism.

[53]  P. Gibson,et al.  Intestinal gases: influence on gut disorders and the role of dietary manipulations , 2019, Nature Reviews Gastroenterology & Hepatology.

[54]  E. Feldman,et al.  Diabetic neuropathy , 2019, Nature Reviews Disease Primers.

[55]  T. Navarro-Rodriguez,et al.  Lactulose Breath Testing Can Be a Positive Predictor Before Weight Gain in Participants with Obesity Submitted to Roux-en-Y Gastric Bypass , 2019, Obesity Surgery.

[56]  Lu Qi,et al.  The short-chain fatty acid propionate increases glucagon and FABP4 production, impairing insulin action in mice and humans , 2019, Science Translational Medicine.

[57]  M. Blüher.  Obesity: global epidemiology and pathogenesis , 2019, Nature Reviews Endocrinology.

[58]  Henry C. Lin,et al.  Reevaluating our understanding of lactulose breath tests by incorporating hydrogen sulfide measurements , 2019, JGH open : an open access journal of gastroenterology and hepatology.

[59]  F. Rivas Ruiz,et al.  Small intestinal bacterial overgrowth is common after gastrectomy but with little impact on nutritional status. , 2019, Gastroenterologia y hepatologia.

[60]  Eunjung Kim,et al.  Cysteine-derived hydrogen sulfide and gut health: a matter of endogenous or bacterial origin , 2019, Current opinion in clinical nutrition and metabolic care.

[61]  Xiao Wang,et al.  Butyrate stimulates hepatic gluconeogenesis in mouse primary hepatocytes , 2018, Experimental and therapeutic medicine.

[62]  S. Hazen,et al.  Dietary metabolism, the gut microbiome, and heart failure , 2018, Nature Reviews Cardiology.

[63]  Mari Iwasaki,et al.  Duodenal chemosensing , 2018, Current opinion in gastroenterology.

[64]  G. Frühbeck,et al.  Ghrelin Reduces TNF-&agr;–Induced Human Hepatocyte Apoptosis, Autophagy, and Pyroptosis: Role in Obesity-Associated NAFLD , 2018, The Journal of clinical endocrinology and metabolism.

[65]  Mianbo Wang,et al.  Treatment of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review , 2018, Rheumatology.

[66]  Z. Torabi,et al.  Liver disease symptoms in non-alcoholic fatty liver disease and small intestinal bacterial overgrowth , 2018, Romanian journal of internal medicine = Revue roumaine de medecine interne.

[67]  P. Hylemon,et al.  Metabolism of hydrogen gases and bile acids in the gut microbiome , 2018, FEBS letters.

[68]  P. Bogdański,et al.  Dose-Dependent Effects of Multispecies Probiotic Supplementation on the Lipopolysaccharide (LPS) Level and Cardiometabolic Profile in Obese Postmenopausal Women: A 12-Week Randomized Clinical Trial , 2018, Nutrients.

[69]  C. Hoffmann,et al.  The human gut microbiota: Metabolism and perspective in obesity , 2018, Gut microbes.

[70]  J. Miyoshi,et al.  Small Intestine Microbiota Regulate Host Digestive and Absorptive Adaptive Responses to Dietary Lipids. , 2018, Cell host & microbe.

[71]  E. Severance,et al.  Obesity increases the risk of small intestinal bacterial overgrowth (SIBO) , 2018, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[72]  C. Malbert,et al.  Impact of gastric emptying and small intestinal transit on blood glucose, intestinal hormones, glucose absorption in the morbidly obese , 2018, International Journal of Obesity.

[73]  M. Akash,et al.  Tumor Necrosis Factor‐Alpha: Role in Development of Insulin Resistance and Pathogenesis of Type 2 Diabetes Mellitus , 2018, Journal of cellular biochemistry.

[74]  J. DiBaise,et al.  Small Intestinal Bacterial Overgrowth: Nutritional Implications, Diagnosis, and Management. , 2017, Gastroenterology clinics of North America.

[75]  L. Olariu,et al.  The relationship between non-alcoholic fatty liver disease and small intestinal bacterial overgrowth among overweight and obese children and adolescents , 2017, Journal of pediatric endocrinology & metabolism : JPEM.

[76]  J. M. Larsen.  The immune response to Prevotella bacteria in chronic inflammatory disease. , 2017, Immunology.

[77]  Joshua A. Salomon,et al.  Health Effects of Overweight and Obesity in 195 Countries over 25 Years. , 2017, The New England journal of medicine.

[78]  H. Parkman,et al.  Elevated methane levels in small intestinal bacterial overgrowth suggests delayed small bowel and colonic transit , 2017, Medicine.

[79]  Baoyan Wang,et al.  Probiotics for Preventing and Treating Small Intestinal Bacterial Overgrowth: A Meta-Analysis and Systematic Review of Current Evidence , 2017, Journal of clinical gastroenterology.

[80]  Henry C. Lin,et al.  Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus , 2017, The American Journal of Gastroenterology.

[81]  S. Rana,et al.  Malabsorption, Orocecal Transit Time and Small Intestinal Bacterial Overgrowth in Type 2 Diabetic Patients: A Connection , 2017, Indian Journal of Clinical Biochemistry.

[82]  S. Msika,et al.  Consequences of Small Intestinal Bacterial Overgrowth in Obese Patients Before and After Bariatric Surgery , 2017, Obesity Surgery.

[83]  C. K. Yao,et al.  The clinical value of breath hydrogen testing , 2017, Journal of gastroenterology and hepatology.

[84]  P. Thota,et al.  Higher visceral to subcutaneous fat ratio is associated with small intestinal bacterial overgrowth. , 2016, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[85]  R. McCallum,et al.  Lubiprostone Accelerates Intestinal Transit and Alleviates Small Intestinal Bacterial Overgrowth in Patients With Chronic Constipation , 2016, The American journal of the medical sciences.

[86]  M. A. Saad,et al.  Linking Gut Microbiota and Inflammation to Obesity and Insulin Resistance. , 2016, Physiology.

[87]  P. Thota,et al.  Small Intestinal Bacterial Overgrowth Is Associated with Non-Alcoholic Fatty Liver Disease. , 2016, Journal of gastrointestinal and liver diseases : JGLD.

[88]  S. Jana,et al.  Hydrogen sulphide in exhaled breath: a potential biomarker for small intestinal bacterial overgrowth in IBS , 2016, Journal of breath research.

[89]  D. Ye,et al.  TNF-α Modulation of Intestinal Tight Junction Permeability Is Mediated by NIK/IKK-α Axis Activation of the Canonical NF-κB Pathway. , 2016, The American journal of pathology.

[90]  L. Wojtczak,et al.  Short- and medium-chain fatty acids in energy metabolism: the cellular perspective , 2016, Journal of Lipid Research.

[91]  A. Di Leo,et al.  Macronutrient intakes in obese subjects with or without small intestinal bacterial overgrowth: an alimentary survey , 2016, Scandinavian journal of gastroenterology.

[92]  Lawrence A. David,et al.  The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota , 2016, Hepatology.

[93]  J. Tack,et al.  Redefining the functional roles of the gastrointestinal migrating motor complex and motilin in small bacterial overgrowth and hunger signaling. , 2016, American journal of physiology. Gastrointestinal and liver physiology.

[94]  B. Massey,et al.  Scintigraphy Demonstrates High Rate of False-positive Results From Glucose Breath Tests for Small Bowel Bacterial Overgrowth. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[95]  M. Pimentel,et al.  How to Test and Treat Small Intestinal Bacterial Overgrowth: an Evidence-Based Approach , 2016, Current Gastroenterology Reports.

[96]  Hong-wei Zhang,et al.  Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults , 2016, Scientific Reports.

[97]  Y. Chawla,et al.  Small intestinal bacterial overgrowth and toll‐like receptor signaling in patients with non‐alcoholic fatty liver disease , 2016, Journal of gastroenterology and hepatology.

[98]  P. Nighot,et al.  Lipopolysaccharide Regulation of Intestinal Tight Junction Permeability Is Mediated by TLR4 Signal Transduction Pathway Activation of FAK and MyD88 , 2015, The Journal of Immunology.

[99]  P. Dagnelie,et al.  Gut colonization with methanobrevibacter smithii is associated with childhood weight development , 2015, Obesity.

[100]  P. Pasricha,et al.  Small Intestinal Transit Time Is Delayed in Small Intestinal Bacterial Overgrowth , 2015, Journal of clinical gastroenterology.

[101]  H. Jang,et al.  Obesity Alters the Microbial Community Profile in Korean Adolescents , 2015, PloS one.

[102]  M. Kleerebezem,et al.  Gut microbiota facilitates dietary heme-induced epithelial hyperproliferation by opening the mucus barrier in colon , 2015, Proceedings of the National Academy of Sciences.

[103]  G. Núñez,et al.  Distinct Commensals Induce Interleukin-1β via NLRP3 Inflammasome in Inflammatory Monocytes to Promote Intestinal Inflammation in Response to Injury. , 2015, Immunity.

[104]  P. Clavé,et al.  Potential role of the gaseous mediator hydrogen sulphide (H2S) in inhibition of human colonic contractility. , 2015, Pharmacological research.

[105]  L. Franchi,et al.  Role of Inflammasomes in Intestinal Inflammation and Crohn's Disease , 2015, Inflammatory bowel diseases.

[106]  C. Couto,et al.  The Role of Intestinal Bacteria Overgrowth in Obesity-Related Nonalcoholic Fatty Liver Disease , 2014, Nutrients.

[107]  D. Gozal,et al.  Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages. , 2014, Cell metabolism.

[108]  M. Pimentel,et al.  Methanogens, Methane and Gastrointestinal Motility , 2013, Journal of neurogastroenterology and motility.

[109]  S. Rao,et al.  Dysmotility and proton pump inhibitor use are independent risk factors for small intestinal bacterial and/or fungal overgrowth , 2013, Alimentary pharmacology & therapeutics.

[110]  G. Barlow,et al.  Methane and hydrogen positivity on breath test is associated with greater body mass index and body fat. , 2013, The Journal of clinical endocrinology and metabolism.

[111]  M. J. Saad,et al.  The Role of Gut Microbiota on Insulin Resistance , 2013, Nutrients.

[112]  A. Walker,et al.  Therapeutic modulation of intestinal dysbiosis. , 2013, Pharmacological research.

[113]  H. Rex Gaskins,et al.  Contributions of the microbial hydrogen economy to colonic homeostasis , 2012, Nature Reviews Gastroenterology &Hepatology.

[114]  D. Jain,et al.  Molecular analysis of gut microbiota in obesity among Indian individuals , 2012, Journal of Biosciences.

[115]  G. Barlow,et al.  Intestinal Methanobrevibacter smithii but not total bacteria is related to diet‐induced weight gain in rats , 2012, Obesity.

[116]  Dae-Wook Kang,et al.  Effects of gut microbes on nutrient absorption and energy regulation. , 2012, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[117]  H. Roche,et al.  Fats, inflammation and insulin resistance: insights to the role of macrophage and T-cell accumulation in adipose tissue , 2011, Proceedings of the Nutrition Society.

[118]  G. Farrugia,et al.  Oxidative stress: key player in gastrointestinal complications of diabetes , 2011, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[119]  B. Finlay,et al.  Gut microbiota in health and disease. , 2010, Physiological reviews.

[120]  Jaroslav Kvetina,et al.  Small intestinal bacterial overgrowth syndrome. , 2010, World journal of gastroenterology.

[121]  D. Ye,et al.  Cellular and molecular mechanism of interleukin-1β modulation of Caco-2 intestinal epithelial tight junction barrier , 2010, Journal of cellular and molecular medicine.

[122]  S. Parajuli,et al.  The inhibitory effects of hydrogen sulfide on pacemaker activity of interstitial cells of cajal from mouse small intestine. , 2010, The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology.

[123]  A. Gasbarrini,et al.  Small bowel bacterial overgrowth and type 1 diabetes. , 2009, European review for medical and pharmacological sciences.

[124]  G. La Torre,et al.  Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease , 2009, Hepatology.

[125]  M. Crowell,et al.  Human gut microbiota in obesity and after gastric bypass , 2009, Proceedings of the National Academy of Sciences.

[126]  P. Clavé,et al.  The gaseous mediator, hydrogen sulphide, inhibits in vitro motor patterns in the human, rat and mouse colon and jejunum , 2008, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[127]  A. Gasbarrini,et al.  Small Intestinal Bacterial Overgrowth Recurrence After Antibiotic Therapy , 2008, The American Journal of Gastroenterology.

[128]  R. Bibiloni,et al.  Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet–Induced Obesity and Diabetes in Mice , 2008, Diabetes.

[129]  J. Ferrières,et al.  Metabolic Endotoxemia Initiates Obesity and Insulin Resistance , 2007, Diabetes.

[130]  Soumya Chatterjee,et al.  The Degree of Breath Methane Production in IBS Correlates With the Severity of Constipation , 2007, The American Journal of Gastroenterology.

[131]  M. McCarthy,et al.  Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice , 2006, Proceedings of the National Academy of Sciences.

[132]  J. Gordon,et al.  A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[133]  Henry C. Lin,et al.  Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[134]  Ting Wang,et al.  The gut microbiota as an environmental factor that regulates fat storage. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[135]  Jiande D. Z. Chen,et al.  Alterations of gastrointestinal motility in obesity. , 2004, Obesity research.

[136]  W. Roediger,et al.  Reducing sulfur compounds of the colon impair colonocyte nutrition: implications for ulcerative colitis. , 1993, Gastroenterology.

[137]  T. Midtvedt,et al.  Short-chain fatty acids in the small-bowel bacterial overgrowth syndrome. , 1985, Scandinavian journal of gastroenterology.

[138]  V. Ojetti,et al.  Diagnosis of small intestinal bacterial overgrowth in the clinical practice. , 2013, European review for medical and pharmacological sciences.

[139]  E. Soffer,et al.  Intestinal methane production in obese individuals is associated with a higher body mass index. , 2012, Gastroenterology & hepatology.

[140]  R. Quera,et al.  Small Intestinal Clustered Contractions and Bacterial Overgrowth: A Frequent Finding in Obese Patients , 2010, Digestive Diseases and Sciences.

[141]  K. L. Johnston,et al.  Small intestinal bacterial overgrowth. , 1999, The Veterinary clinics of North America. Small animal practice.

[142]  P. Malfertheiner,et al.  Interdigestive gastroduodenal motility and cycling of putative regulatory hormones in severe obesity. , 1992, Scandinavian journal of gastroenterology.